Rivastigmine Transdermal Patches Bioequivalence and Adhesion Assessment

by palligoelme@gmail.com | Mar 11, 2026 | Clinical Trials

​ Conditions: Bioequivalence Study in Healthy Subjects Interventions: Drug: Rivastigmine TDS 9,5 mg/24 h; Drug: Exelon® 9.5 mg/24 h Sponsors: Zodiac Produtos Farmaceuticos S.A. Completed Conditions: Bioequivalence Study in Healthy Subjects Interventions: Drug:...

Cardiac Morphology and Function in Individuals With Autonomic Dysreflexia

by palligoelme@gmail.com | Mar 11, 2026 | Clinical Trials

​ Conditions: Autonomic Dysreflexia; Spinal Cord Injuries and Disorders (SCI/D); Cardiac Remodeling Sponsors: Swiss Paraplegic Research, Nottwil Not yet recruiting Conditions: Autonomic Dysreflexia; Spinal Cord Injuries and Disorders (SCI/D); Cardiac Remodeling...

Assesment of the Clinical Benefit of Provocation on Tilt-table in SYNCope Patients, TiltSYNC-trial

by palligoelme@gmail.com | Mar 11, 2026 | Clinical Trials

​ Conditions: Vasovagal Syncope (VVS) Interventions: Diagnostic Test: biofeedback and standard of care with tilt table testing; Diagnostic Test: no tilt table testing Sponsors: Academisch Medisch Centrum – Universiteit van Amsterdam (AMC-UvA)...

The Influence of Anemia on HbA1c Readings in Non-Diabetic Patients

by palligoelme@gmail.com | Mar 11, 2026 | Clinical Trials

​ Conditions: Anemia; HbA1c Sponsors: Sohag University Not yet recruiting Conditions: Anemia; HbA1c Sponsors: Sohag University Not yet recruiting 

Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC

by palligoelme@gmail.com | Mar 11, 2026 | Clinical Trials

​ Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC); Squamous Cell Carcinoma of the Head and Neck Interventions: Drug: Ficerafusp alfa; Drug: Pembrolizumab Sponsors: Dana-Farber Cancer Institute; Bicara Therapeutics Not yet recruiting Conditions: Head and Neck...

Comparison of Mean Duration of Analgesia Following the Administration of Bupivacaine With and Without Magnesium Sulphate in Ultrasound Guided Erector Spinae Plane Block in Modified Radical Mastectomy Patients

by palligoelme@gmail.com | Mar 10, 2026 | Clinical Trials

​ Conditions: Modified Radical Mastectomy Interventions: Drug: Group B (bupivacaine); Drug: Bupivacaine plus magnesium sulfate Sponsors: Gulab Devi Hospital Completed Conditions: Modified Radical Mastectomy Interventions: Drug: Group B (bupivacaine); Drug: Bupivacaine...